Abstract
Transvitreal fibrin web is an uncommon consequence of pars plana vitrectomy, seen predominantly in diabetic patients. It is an early postoperative response and is treated with topical corticosteroids, although some cases may warrant the use of tissue plasminogen activator intravitreally, or re-surgery as in our case. Fibrin web should be differentiated from endophthalmitis so as to avoid panic and improper management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
